ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Inflammation Disrupts Memory - What Can You Do to Protect Your Brain?

Artificial sweeteners linked to risk of weight gain, heart disease and other health issues

All About Ginkgo Biloba: Benefits of This Timeless Herbal Supplement

Yarrow Oil: Here's Why It Deserves a Place in Your First-Aid Kit

Vitamin D supplement use associated with lower risk of breast cancer

Carnitine deficiency suggested as contributor to autism

Hop Oil: A Safe Sleep Aide

Lutein — An Important Nutrient for Eye and Brain Health

White Camphor Oil: The Purest Camphor Oil

Taurine: Facts About This Crucial Amino Acid

 
Print Page
Email Article

Rheumatoid Arthritis Drug to Enter Phase III Clinical Studies

  [ 15 votes ]   [ Discuss This Article ]
www.ProHealth.com • December 14, 2001




The U.S. Food and Drug Administration has granted permission to begin a Phase III study with HuMaxTM-CD4 to treat patients with active rheumatoid arthritis (RA) who have failed to respond to treatment with methotrexate and TNF-alpha blocking agents. These patients represent a major unmet medical need, as they do not have an effective treatment option.

The objective of the Phase III trial is to confirm the safety and efficacy of HuMax-CD4 in the treatment of RA. The study will enroll 400 patients who will be treated with either 80 or 160 milligrams of HuMax-CD4 or placebo for a total of 26 weeks. The patients will be given two doses, two weeks apart, followed by one dose each month. The Phase III trial will be initiated in the US and Europe in December 2001, and is planned to take place at over 50 locations.

HuMax-CD4 is a high affinity fully human antibody that targets the CD4 receptor on T-lymphocytes. These cells are involved in promoting autoimmune disease and an antibody that targets them can be used for the treatment of several inflammatory diseases including rheumatoid arthritis and psoriasis. HuMax-CD4 has been studied in both Rheumatoid Arthritis (RA) and Psoriasis clinical trials.

In previous studies, HuMax-CD4 was reported safe and well tolerated. In a Phase I/II RA study, fifty percent of the treated patients in the four highest dose cohorts, achieved favorable responses to the antibody as measured by objective criteria defined by the American College of Rheumatology (ACR). They achieved responses ranging from ACR 20 to ACR 70.

The dose response observed in the Phase I/II RA study correlates with the initial results of the HuMax-CD4 Phase II dose finding study in psoriasis patients, where the antibody has shown a statistically significant dose response. In addition, mean Psoriasis Area Severity Index (PASI) score was reduced in all treatment groups with a 30% difference between the placebo and 160mg dose groups. HuMax-CD4 was also safe and well tolerated.

The psoriasis trial was a small placebo controlled Phase II study designed to establish the safety and lowest effective dose of HuMax-CD4 in patients with moderate to severe psoriasis. Patients received either one of four dose levels or placebo weekly for four weeks. Eighty-five patients were followed for a total of 16 weeks and final results of the study will be presented early next year.



Post a Comment

Featured Products From the ProHealth Store
FibroSleep™ Ultra EPA  - Fish Oil Ultra ATP+, Double Strength


Article Comments



Be the first to comment on this article!

Post a Comment


 
NAD+ Ignite with Niagen

Featured Products

Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium

Natural Remedies

Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health
Vitamin K-2 – A Key Player in Cardiovascular and Bone Health Vitamin K-2 – A Key Player in Cardiovascular and Bone Health
Why Berries Offer a Rainbow of Health Benefits Why Berries Offer a Rainbow of Health Benefits
Thyroid Health and Fibromyalgia Thyroid Health and Fibromyalgia
Enhance Eyelashes Naturally Enhance Eyelashes Naturally

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map